Annual SG&A
$917.14 M
+$43.13 M+4.94%
30 June 2024
Summary:
ResMed annual selling, general & administrative expenses is currently $917.14 million, with the most recent change of +$43.13 million (+4.94%) on 30 June 2024. During the last 3 years, it has risen by +$246.75 million (+36.81%). RMD annual SG&A is now at all-time high.RMD Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$238.98 M
-$3.21 M-1.33%
30 September 2024
Summary:
ResMed quarterly selling, general & administrative expenses is currently $238.98 million, with the most recent change of -$3.21 million (-1.33%) on 30 September 2024. Over the past year, it has increased by +$16.11 million (+7.23%). RMD quarterly SG&A is now -1.33% below its all-time high of $242.19 million, reached on 30 June 2024.RMD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
$19.53 B
+$823.27 M+4.40%
30 September 2024
Summary:
ResMed TTM selling, general & administrative expenses is currently $19.53 billion, with the most recent change of +$823.27 million (+4.40%) on 30 September 2024. Over the past year, it has increased by +$18.62 billion (+2060.77%). RMD TTM SG&A is now at all-time high.RMD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMD Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.9% | +7.2% | +2060.8% |
| 3 y3 years | +36.8% | +35.2% | +2737.7% |
| 5 y5 years | +42.2% | +42.7% | +2835.7% |
RMD Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.8% | -1.3% | +35.2% | at high | +58.5% |
| 5 y | 5 years | at high | +42.2% | -1.3% | +50.3% | at high | +100.8% |
| alltime | all time | at high | >+9999.0% | -1.3% | +8140.7% | at high | >+9999.0% |
ResMed Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $238.98 M(-1.3%) | $933.24 M(+1.8%) |
| June 2024 | $917.14 M(+4.9%) | $242.19 M(+5.3%) | $917.14 M(+0.2%) |
| Mar 2024 | - | $229.92 M(+3.5%) | $915.63 M(+0.2%) |
| Dec 2023 | - | $222.16 M(-0.3%) | $914.17 M(+1.2%) |
| Sept 2023 | - | $222.87 M(-7.4%) | $903.69 M(+3.3%) |
| June 2023 | $874.00 M(+18.5%) | $240.69 M(+5.4%) | $874.75 M(+5.8%) |
| Mar 2023 | - | $228.46 M(+7.9%) | $827.09 M(+5.9%) |
| Dec 2022 | - | $211.67 M(+9.1%) | $781.03 M(+3.5%) |
| Sept 2022 | - | $193.93 M(+0.5%) | $754.72 M(+2.3%) |
| June 2022 | $737.51 M(+10.0%) | $193.03 M(+5.8%) | $737.51 M(+1.6%) |
| Mar 2022 | - | $182.40 M(-1.6%) | $725.97 M(+3.1%) |
| Dec 2021 | - | $185.36 M(+4.9%) | $704.01 M(+2.3%) |
| Sept 2021 | - | $176.72 M(-2.6%) | $688.12 M(+2.6%) |
| June 2021 | $670.39 M(-0.9%) | $181.48 M(+13.1%) | $670.39 M(+2.5%) |
| Mar 2021 | - | $160.45 M(-5.3%) | $654.29 M(-1.8%) |
| Dec 2020 | - | $169.47 M(+6.6%) | $666.28 M(-0.3%) |
| Sept 2020 | - | $158.99 M(-3.9%) | $668.24 M(-1.2%) |
| June 2020 | $676.69 M(+4.9%) | $165.38 M(-4.1%) | $676.69 M(-0.9%) |
| Mar 2020 | - | $172.44 M(+0.6%) | $682.90 M(+1.2%) |
| Dec 2019 | - | $171.42 M(+2.4%) | $674.99 M(+1.5%) |
| Sept 2019 | - | $167.44 M(-2.4%) | $665.15 M(+3.1%) |
| June 2019 | $645.01 M(+7.4%) | $171.60 M(+4.3%) | $645.01 M(+2.3%) |
| Mar 2019 | - | $164.53 M(+1.8%) | $630.22 M(+2.7%) |
| Dec 2018 | - | $161.58 M(+9.7%) | $613.59 M(+1.6%) |
| Sept 2018 | - | $147.30 M(-6.1%) | $603.82 M(+0.6%) |
| June 2018 | $600.37 M(+8.4%) | $156.81 M(+6.0%) | $600.37 M(+1.5%) |
| Mar 2018 | - | $147.89 M(-2.6%) | $591.50 M(+1.7%) |
| Dec 2017 | - | $151.82 M(+5.5%) | $581.47 M(+2.2%) |
| Sept 2017 | - | $143.85 M(-2.8%) | $568.96 M(+2.7%) |
| June 2017 | $553.97 M(+13.5%) | $147.94 M(+7.3%) | $553.96 M(+2.2%) |
| Mar 2017 | - | $137.86 M(-1.0%) | $541.87 M(+2.8%) |
| Dec 2016 | - | $139.31 M(+8.1%) | $526.90 M(+4.2%) |
| Sept 2016 | - | $128.85 M(-5.1%) | $505.81 M(+3.6%) |
| June 2016 | $488.06 M(+2.0%) | $135.84 M(+10.5%) | $488.06 M(+1.4%) |
| Mar 2016 | - | $122.90 M(+4.0%) | $481.46 M(+1.4%) |
| Dec 2015 | - | $118.22 M(+6.4%) | $474.90 M(-0.9%) |
| Sept 2015 | - | $111.09 M(-14.0%) | $479.20 M(+0.1%) |
| June 2015 | $478.63 M(+6.3%) | $129.25 M(+11.1%) | $478.63 M(+1.5%) |
| Mar 2015 | - | $116.34 M(-5.0%) | $471.62 M(+0.3%) |
| Dec 2014 | - | $122.52 M(+10.9%) | $470.38 M(+2.3%) |
| Sept 2014 | - | $110.52 M(-9.6%) | $459.61 M(+2.0%) |
| June 2014 | $450.41 M(+4.6%) | $122.24 M(+6.2%) | $450.41 M(+1.6%) |
| Mar 2014 | - | $115.10 M(+3.0%) | $443.23 M(+1.3%) |
| Dec 2013 | - | $111.75 M(+10.3%) | $437.76 M(+0.9%) |
| Sept 2013 | - | $101.32 M(-11.9%) | $433.82 M(+0.7%) |
| June 2013 | $430.80 M(+7.0%) | $115.06 M(+5.0%) | $430.80 M(+2.2%) |
| Mar 2013 | - | $109.63 M(+1.7%) | $421.65 M(+1.9%) |
| Dec 2012 | - | $107.81 M(+9.7%) | $413.99 M(+1.8%) |
| Sept 2012 | - | $98.30 M(-7.2%) | $406.72 M(+1.0%) |
| June 2012 | $402.62 M(+8.2%) | $105.91 M(+3.9%) | $402.62 M(+0.6%) |
| Mar 2012 | - | $101.96 M(+1.4%) | $400.04 M(+2.4%) |
| Dec 2011 | - | $100.55 M(+6.7%) | $390.63 M(+2.4%) |
| Sept 2011 | - | $94.20 M(-8.8%) | $381.66 M(+2.5%) |
| June 2011 | $372.25 M(+13.2%) | $103.33 M(+11.6%) | $372.25 M(+5.5%) |
| Mar 2011 | - | $92.55 M(+1.1%) | $352.80 M(+2.4%) |
| Dec 2010 | - | $91.58 M(+8.0%) | $344.38 M(+2.2%) |
| Sept 2010 | - | $84.79 M(+1.1%) | $336.89 M(+2.4%) |
| June 2010 | $328.86 M | $83.87 M(-0.3%) | $328.86 M(+0.9%) |
| Mar 2010 | - | $84.13 M(+0.0%) | $326.07 M(+4.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | - | $84.09 M(+9.6%) | $312.80 M(+4.7%) |
| Sept 2009 | - | $76.76 M(-5.3%) | $298.79 M(+1.8%) |
| June 2009 | $293.38 M(+5.5%) | $81.09 M(+14.4%) | $293.38 M(+1.3%) |
| Mar 2009 | - | $70.87 M(+1.1%) | $289.73 M(+0.3%) |
| Dec 2008 | - | $70.09 M(-1.8%) | $288.98 M(+0.9%) |
| Sept 2008 | - | $71.34 M(-7.9%) | $286.54 M(+3.0%) |
| June 2008 | $278.09 M(+17.2%) | $77.44 M(+10.4%) | $278.09 M(+4.6%) |
| Mar 2008 | - | $70.12 M(+3.7%) | $265.86 M(+3.4%) |
| Dec 2007 | - | $67.64 M(+7.6%) | $257.07 M(+4.2%) |
| Sept 2007 | - | $62.88 M(-3.6%) | $246.76 M(+4.0%) |
| June 2007 | $237.33 M(+18.6%) | $65.21 M(+6.3%) | $237.33 M(+5.5%) |
| Mar 2007 | - | $61.34 M(+7.0%) | $225.04 M(+3.7%) |
| Dec 2006 | - | $57.34 M(+7.3%) | $217.12 M(+3.9%) |
| Sept 2006 | - | $53.44 M(+1.0%) | $208.93 M(+4.4%) |
| June 2006 | $200.17 M(+47.5%) | $52.93 M(-0.9%) | $200.17 M(+6.6%) |
| Mar 2006 | - | $53.41 M(+8.7%) | $187.86 M(+11.2%) |
| Dec 2005 | - | $49.15 M(+10.0%) | $168.90 M(+10.2%) |
| Sept 2005 | - | $44.68 M(+10.0%) | $153.22 M(+13.3%) |
| June 2005 | $135.70 M(+29.6%) | $40.62 M(+17.9%) | $135.20 M(+9.8%) |
| Mar 2005 | - | $34.45 M(+2.9%) | $123.14 M(+5.3%) |
| Dec 2004 | - | $33.47 M(+25.5%) | $116.89 M(+7.1%) |
| Sept 2004 | - | $26.66 M(-6.6%) | $109.18 M(+4.3%) |
| June 2004 | $104.71 M(+22.7%) | $28.55 M(+1.2%) | $104.71 M(+2.9%) |
| Mar 2004 | - | $28.20 M(+9.5%) | $101.73 M(+7.6%) |
| Dec 2003 | - | $25.77 M(+16.1%) | $94.54 M(+5.4%) |
| Sept 2003 | - | $22.19 M(-13.3%) | $89.71 M(+5.3%) |
| June 2003 | $85.31 M(+32.3%) | $25.58 M(+21.7%) | $85.21 M(+8.3%) |
| Mar 2003 | - | $21.01 M(+0.4%) | $78.65 M(+6.2%) |
| Dec 2002 | - | $20.93 M(+18.3%) | $74.04 M(+9.1%) |
| Sept 2002 | - | $17.69 M(-7.0%) | $67.89 M(+5.3%) |
| June 2002 | $64.48 M(+29.2%) | $19.01 M(+15.9%) | $64.48 M(+5.1%) |
| Mar 2002 | - | $16.41 M(+11.1%) | $61.34 M(+4.6%) |
| Dec 2001 | - | $14.77 M(+3.4%) | $58.66 M(+7.4%) |
| Sept 2001 | - | $14.29 M(-10.0%) | $54.61 M(+9.4%) |
| June 2001 | $49.91 M(+35.0%) | $15.87 M(+15.6%) | $49.91 M(+13.0%) |
| Mar 2001 | - | $13.73 M(+28.0%) | $44.16 M(+10.7%) |
| Dec 2000 | - | $10.72 M(+11.8%) | $39.90 M(+4.5%) |
| Sept 2000 | - | $9.59 M(-5.3%) | $38.17 M(+3.2%) |
| June 2000 | $36.99 M(+35.0%) | $10.12 M(+7.0%) | $36.98 M(+7.6%) |
| Mar 2000 | - | $9.46 M(+5.1%) | $34.36 M(+9.1%) |
| Dec 1999 | - | $9.00 M(+7.1%) | $31.50 M(+7.1%) |
| Sept 1999 | - | $8.40 M(+12.0%) | $29.40 M(+7.3%) |
| June 1999 | $27.40 M(+29.9%) | $7.50 M(+13.6%) | $27.40 M(+5.4%) |
| Mar 1999 | - | $6.60 M(-4.3%) | $26.00 M(+5.3%) |
| Dec 1998 | - | $6.90 M(+7.8%) | $24.70 M(+8.3%) |
| Sept 1998 | - | $6.40 M(+4.9%) | $22.80 M(+8.1%) |
| June 1998 | $21.10 M(+25.6%) | $6.10 M(+15.1%) | $21.10 M(+7.1%) |
| Mar 1998 | - | $5.30 M(+6.0%) | $19.70 M(+6.5%) |
| Dec 1997 | - | $5.00 M(+6.4%) | $18.50 M(+5.1%) |
| Sept 1997 | - | $4.70 M(0.0%) | $17.60 M(+4.8%) |
| June 1997 | $16.80 M(+20.0%) | $4.70 M(+14.6%) | $16.80 M(-9.7%) |
| Mar 1997 | - | $4.10 M(0.0%) | $18.60 M(+6.9%) |
| Dec 1996 | - | $4.10 M(+5.1%) | $17.40 M(+30.8%) |
| Sept 1996 | - | $3.90 M(-40.0%) | $13.30 M(+41.5%) |
| June 1996 | $14.00 M(+48.9%) | $6.50 M(+124.1%) | $9.40 M(+224.1%) |
| Mar 1996 | - | $2.90 M | $2.90 M |
| June 1995 | $9.40 M(+46.9%) | - | - |
| June 1994 | $6.40 M(+64.1%) | - | - |
| June 1993 | $3.90 M | - | - |
FAQ
- What is ResMed annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ResMed?
- What is ResMed annual SG&A year-on-year change?
- What is ResMed quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ResMed?
- What is ResMed quarterly SG&A year-on-year change?
- What is ResMed TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ResMed?
- What is ResMed TTM SG&A year-on-year change?
What is ResMed annual selling, general & administrative expenses?
The current annual SG&A of RMD is $917.14 M
What is the all time high annual SG&A for ResMed?
ResMed all-time high annual selling, general & administrative expenses is $917.14 M
What is ResMed annual SG&A year-on-year change?
Over the past year, RMD annual selling, general & administrative expenses has changed by +$43.13 M (+4.94%)
What is ResMed quarterly selling, general & administrative expenses?
The current quarterly SG&A of RMD is $238.98 M
What is the all time high quarterly SG&A for ResMed?
ResMed all-time high quarterly selling, general & administrative expenses is $242.19 M
What is ResMed quarterly SG&A year-on-year change?
Over the past year, RMD quarterly selling, general & administrative expenses has changed by +$16.11 M (+7.23%)
What is ResMed TTM selling, general & administrative expenses?
The current TTM SG&A of RMD is $19.53 B
What is the all time high TTM SG&A for ResMed?
ResMed all-time high TTM selling, general & administrative expenses is $933.24 M
What is ResMed TTM SG&A year-on-year change?
Over the past year, RMD TTM selling, general & administrative expenses has changed by +$18.62 B (+2060.77%)